Asthma is a chronic disease. Specifically, it is a chronic inflammatory disease of the airways, classified alongside other long-term respiratory conditions. In the United States, about 8.6% of adults and 6.5% of children currently live with it. Unlike an acute illness that resolves on its own, asthma involves ongoing changes in the lungs that require long-term management.
What Kind of Disease Asthma Is
Asthma is categorized as a chronic respiratory disease, meaning it affects the airways over months, years, or a lifetime. The defining features are inflammation of the airway lining, intermittent obstruction of airflow, and an exaggerated sensitivity of the airways to triggers. These three characteristics set asthma apart from a temporary infection like bronchitis or pneumonia, where the lungs typically return to normal after recovery.
There is no single version of asthma. Researchers recognize at least four distinct biological types based on which immune cells drive the inflammation. In some people, a type of white blood cell called an eosinophil dominates, producing the classic allergic pattern. In others, neutrophils (a different immune cell) are the main driver, and the condition responds differently to treatment. Two other patterns involve a mix of both cell types or very little inflammatory cell involvement at all. These distinctions matter because they influence which treatments work best.
How Asthma Affects the Airways
When someone with asthma encounters a trigger (dust, pollen, cold air, smoke, exercise), their immune system overreacts. Antibodies on the surface of mast cells recognize the trigger and cause those cells to release chemicals like histamine. These chemicals make the smooth muscle surrounding the airways contract and tighten, narrowing the space air has to flow through. This tightening is called bronchoconstriction, and it happens within minutes.
Over the next several hours, a second wave of immune activity brings additional white blood cells into the lungs, sustaining the inflammation. The airway lining swells, and glands in the airways produce excess mucus. Between the muscle tightening, the swelling, and the mucus, the breathing passages become significantly smaller. That combination is what produces the characteristic wheezing, coughing, chest tightness, and shortness of breath.
Over time, repeated episodes of inflammation cause structural changes in the airways. The layer beneath the airway lining thickens with collagen. The smooth muscle itself grows in mass. Cells in the airway wall can shift their identity, becoming tissue that produces even more muscle and scar-like material. These changes, collectively called airway remodeling, can make the airways permanently less flexible and more reactive, which is one reason asthma tends to persist.
What Causes It to Develop
Asthma results from a combination of genetic susceptibility and environmental exposure. Dozens of genes are involved, falling into four broad categories: genes that govern the innate immune system, genes that control the allergic immune response, genes involved in the protective lining of the airways, and genes that influence lung function and airway remodeling. No single gene causes asthma on its own, but certain combinations raise the risk substantially.
Environmental factors act on that genetic foundation. Air pollution, tobacco smoke, respiratory viruses (especially in early childhood), indoor and outdoor allergens, and certain workplace exposures all contribute. Diet may also play a role. Someone with a strong genetic predisposition might develop asthma after relatively mild environmental exposure, while someone with fewer risk genes might never develop it despite similar conditions.
Is Asthma Curable?
There is currently no cure for asthma, but it can go into remission. Remission rates vary widely by age. Among children and adolescents, somewhere between 33% and 53% experience remission, meaning they have no symptoms and use no medication. In young adults, the range drops to 6% to 33%. A long-term Dutch study that followed allergic asthmatic children for 30 years found that clinical remission occurred in 30% and complete remission in 22%. For adults who develop asthma later in life, about 16% achieve remission within five years.
These numbers highlight an important paradox: asthma is a disease with no known cure, yet it sometimes resolves on its own. Doctors cannot predict reliably who will outgrow it and who will not. For most people, managing asthma means treating it as a long-term condition while remaining open to the possibility that it may improve over time.
How It Is Diagnosed
Diagnosis typically involves a breathing test called spirometry. You blow as hard and fast as you can into a tube, and the device measures how much air you exhale in the first second compared to the total amount you can push out. If that ratio falls below 0.7, it indicates airway obstruction. Then you inhale a medication that relaxes the airway muscles, and the test is repeated. If your first-second volume improves by at least 12% and at least 200 milliliters, that reversibility strongly suggests asthma rather than a fixed obstruction like emphysema.
Spirometry alone does not always capture the full picture, especially if your airways happen to be open on the day of the test. In those cases, doctors may use challenge tests that deliberately provoke mild airway narrowing, or they may monitor your peak airflow at home over several weeks to look for the variability that characterizes asthma.
How Asthma Is Managed
Current international guidelines recommend that every person with asthma use an inhaler containing a corticosteroid, which reduces airway inflammation. The days of relying on a rescue inhaler alone (a short-acting bronchodilator that only opens the airways temporarily) are over. Using a bronchodilator without an anti-inflammatory component does nothing to address the underlying disease and is associated with worse outcomes.
Treatment follows a stepwise approach. At the mildest level, you use a combination anti-inflammatory and bronchodilator inhaler only when symptoms arise. If that is not enough, you add a daily maintenance dose. At moderate levels, the same combination inhaler serves as both your daily controller and your as-needed reliever, an approach that reduces severe flare-ups compared to using separate inhalers. For people whose asthma remains uncontrolled despite these steps, additional medications that target different parts of the airway muscle or injectable biologic therapies that block specific immune signals can be added.
Severity and Risk
Most people with asthma can achieve good control with appropriate treatment. But asthma is not a trivial diagnosis. In 2021, 3,517 people in the United States died from asthma, including 145 children. The death rate was considerably higher in adults (13.1 per million) than in children (2.0 per million). Nearly all asthma deaths are considered preventable with proper management, which underscores why asthma is treated as a serious chronic disease rather than an inconvenience.
Uncontrolled asthma carries risks beyond acute attacks. Repeated inflammation accelerates airway remodeling, which can lead to permanent loss of lung function over the years. People with poorly controlled asthma also face higher rates of anxiety, disrupted sleep, missed work or school, and reduced physical activity. Treating asthma as the chronic disease it is, rather than something to address only during flare-ups, is what prevents those long-term consequences.